Limited Quantities Available! Order Today and Enjoy Free Shipping on Orders Over $100!
August 17, 2026
Fructose is not only something we eat. Under certain conditions, the body makes it from glucose through the polyol pathway. That discovery changes the model from a simple sugar-intake story into a broader account of metabolic stress.
High glucose and concentrated body fluids can activate this route in defined experimental settings. The fructose produced inside a susceptible tissue can then reach KHK and create the same paired event: ATP/phosphate drawdown alongside uric-acid, redox, and mitochondrial pressure.
Different triggers do not all act identically, but they may converge on the same energetic landscape.
The polyol pathway has two steps:
If the tissue expresses KHK, that new fructose can be converted to F1P and enter the mechanism described in Paper 1. [ENDO-L2013]
This is important because “I did not eat fructose” does not always mean “my cells did not encounter fructose.” The pathway can be activated from inside.
The first step also spends NADPH, a resource used in antioxidant defense and cellular maintenance. The pathway can therefore add redox pressure even before its fructose product reaches KHK. This makes endogenous fructose a particularly interesting bridge: the route that creates the substrate may already be weakening the conditions needed to process it safely.
When intracellular glucose rises, more substrate becomes available to aldose reductase. In diabetic kidney and brain models, sorbitol and fructose rise alongside injury, and disrupting KHK reduces selected redox, mitochondrial, cognitive, or tissue effects.
This creates a plausible bridge from repeated glucose pressure to fructose biology. Glucose and fructose are not metabolically identical, yet high glucose can feed a route that ends at KHK.
In 2026, that bridge moved beyond animal models. During a 75-gram oral glucose tolerance test, serum fructose rose at 30 and 60 minutes in fourteen people with hereditary fructose intolerance and fourteen matched healthy controls—even though the challenge contained glucose, not fructose. This is direct human evidence consistent with internal fructose production after a glucose load. The human study did not isotope-label the glucose, locate the producing tissue, or measure how much fructose reached KHK, so it establishes the response without yet defining its full physiological importance. [ENDO-B2026]
The same study supplied a second piece of the map in mice. Isotope-labelled glucose carbon appeared in hepatic F1P, and blocking aldose reductase lowered liver fructose under fructose-free conditions. This directly strengthens the route-level case that excess glucose can become fructose inside the liver. Liver fat did not fall during the short nine-day intervention, but that experiment was not evidence that switching off an upstream contributor should rapidly reverse established fat. The result is most relevant to how metabolic stress may begin or be reinforced—not as a test of treatment for existing disease. [ENDO-B2026]
The practical implication is not that every carbohydrate becomes fructose. It is that persistent hyperglycemia may keep the pathway relevant even when added fructose is reduced.
When body fluids become more concentrated, cells activate osmotic-defense programs. In sustained hyperosmolar and recurrent-dehydration models, polyol-pathway fructose rises and selected metabolic or kidney effects become KHK-sensitive. [ENDO-S2018]
The survival logic is compelling. An animal facing drought benefits from conserving water, storing fuel, and making metabolic water when fat is later burned. A temporary water-saving program can be adaptive. Continuous osmotic pressure can turn the same logic into a burden.
Salt and dehydration also act through other pathways, so KHK is not their universal explanation. It is a tested point of convergence in particular tissues and conditions.
Alcohol appears to recruit the fructose pathway from within. In mice, ethanol raised portal-vein osmolality, activated aldose reductase and the polyol pathway in the liver and intestine, and increased tissue sorbitol and fructose. The response depended partly on concentration: diluting the ethanol markedly weakened the osmotic and aldose-reductase response. [ENDO-A2025]
This was more than a biochemical resemblance. Removing aldose reductase or KHK reduced alcohol seeking in several mouse paradigms, while global or liver-specific KHK deletion protected against alcohol-associated steatosis, inflammation, and fibrosis under matched exposure. Human alcoholic-liver-disease tissue also points in the same direction, but the decisive interventions remain animal experiments. The pathway is therefore established in experimental models; what remains uncertain is how much it contributes across different patterns of human drinking.
Low oxygen is also tissue-specific. It reduces oxidative energy production directly and can alter KHK expression or fructose use in some heart and tumor models. The pathway does not respond the same way in every organ.
Stress hormones raise glucose and change fuel allocation, making a connection to the polyol pathway plausible. Direct evidence that psychological stress produces clinically important fructose flux remains a research question.
These are not retreating caveats. They are a useful map: high glucose, osmotic stress, and alcohol are established roads in experimental models; hypoxia and hormonal stress are important intersections whose exact traffic still needs measuring.
Tissue identity matters throughout. A kidney under diabetic pressure, a heart adapting to low oxygen, and a liver processing alcohol do not express the same enzymes or face the same demands. A useful unifying model should predict shared logic without demanding identical molecular traffic in every organ.
Endogenous fructose can make metabolic dysfunction feed itself:
The loop explains why changing one food may help without fully resolving the underlying state. Once the system is generating its own trigger, recovery also requires improving glucose control, hydration, sleep, oxygenation, activity, and the health of the affected tissue.
This map helps explain why very different diet and lifestyle programs can produce overlapping benefits. They may be closing different entrances into the same stressed system:
This does not mean that every benefit of a Mediterranean, low-carbohydrate, whole-food, fasting, exercise, or sleep program is mediated by KHK. It means these approaches can converge: each reduces one or more challenges, improves recovery, or does both.
The same map explains why progress can stall. A low-sugar diet may leave alcohol, hyperglycemia, dehydration, poor sleep, or inactivity untouched. Better sleep may improve recovery without removing rapid dietary loads. Once fatty liver, insulin resistance, vascular dysfunction, or mitochondrial damage has become self-reinforcing, removing the original trigger may no longer be enough to restore the system quickly.
A plateau is therefore not necessarily evidence that an approach was wrong. It may mean that one entrance has been closed while another remains open—or that the downstream system now needs time and additional support to rebuild capacity. That is a more useful question than arguing over which single diet is universally correct.
The polyol pathway unifies debates that otherwise seem unrelated. Sugar intake, high glucose, salt balance, dehydration, alcohol, and hypoxia can all affect cellular energy, although not always through the same route or with the same strength.
The model's stronger claim is not that every stressor secretly becomes fructose. It is that KHK can sit inside a larger stress network, receiving fructose from both diet and internal production while other pressures simultaneously reduce the capacity to recover from it.
That idea also creates a practical research strategy. Instead of asking only how much fructose a person ate, investigators can ask where fructose was produced, whether it reached KHK, how large the F1P and uric-acid response became, and how long the affected tissue took to restore its energy state.
Endogenous fructose is the bridge between the food environment and the cell's internal stress response.
It shows how a pathway used for short-term adaptation can remain active after the obvious dietary trigger has been removed. It also explains why recovery must be broader than avoidance: reduce major external loads, but also change the internal conditions that keep generating the signal.
The Fructose Model becomes more unified at this point. Different challenges can arrive by different roads and still meet at the same energetic bottleneck.
Sources are linked inline; full citations and evidence boundaries are available in the Master Bibliography.